share_log

Stifel Initiates Coverage On Kura Oncology With Buy Rating, Announces Price Target of $25

Benzinga Real-time News ·  Jan 31, 2023 04:37

Stifel analyst Bradley Canino initiates coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and announces Price Target of $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment